This site is intended for health professionals only

Home / News / Keele University awarded over £2m to investigate opioid overprescribing

Keele University awarded over £2m to investigate opioid overprescribing


By Léa Legraien
Reporter

15 Jan 2019

A university has been given more than £2m to conduct research into opiod overprescribing in the NHS.

Keele University received a £2.4m grant from the state-funded body the National Institute for Health Research (NIHR) to explore the causes of painkiller overprescribing and train GP pharmacists to better help patients with long-term pain.

In December, health and social care secretary Matt Hancock announced the launch of a review looking at ‘problematic polypharmacy’ in the NHS, which will be led by England’s chief pharmaceutical officer Keith Ridge.

 

Reducing ‘inappropriate’ opioid use

 

The Keele University study aims to reduce ‘inappropriate’ opioid prescribing and improve the quality of life for people suffering persistent pain caused by conditions such as osteoarthritis.

The researchers will also look for alternatives to opioid use, support patients to self-care and train practice-based pharmacists to better assist patients with long-term pain.

Study lead Dr Julie Ashworth said: ‘Patients with persistent pain often see no alternative to continuing opioids, even when they are no longer helpful or cause troublesome side-effects.

‘In addition to reducing use of medicines that may be harming rather than helping patients, if successful, this research will ultimately also reduce NHS prescribing costs and free-up scarce resources to reinvest in more effective treatments.’

It is estimated that the use of morphine-like painkillers increased by a third between 1998 and 2016. People relying on opioids are more likely to have a poor quality of life and suffer bone fracture, addiction and overdoses than those who do not take the medicines, according to research.

 

Preventing complications

 

Pharmacy minister Steve Brine said that intervening more efficiently at primary care level could ‘prevent the complications that arise from long-term opioid use, which improves the quality of care for patients and reduces the burden on the NHS in the long-term’.

He added: ‘This exciting research comes at a time when we are tackling overprescribing head on to improve the care of those with long-term conditions and to reduce prescribing costs across the whole NHS.’


Want news like this straight to your inbox?


Latest News

Plan B
Government must consider ‘sensible measures’ to protect pharmacy teams this winter, RPS says
The Royal Pharmaceutical Society (RPS) is calling on the Government to implement ‘sensible measures’ to...
antiviral drugs
Covid antiviral drugs could be prescribed to prevent hospital admission ‘this winter’
The Government has made deals for hundreds of thousands of doses of two new antiviral...
Chronic fatigue
NICE to publish chronic fatigue guideline after final meeting next week
NICE will publish its long-anticipated updated guideline for myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS)...